Menu Close

Aesthetic injectable companies. The Beauty Health Company reports record Q4 2021

Biorevitalization

THE WHAT? The Beauty Health Company has reported its results for the fourth quarter and full year of fiscal 2021. The owner of Hydrafacial said that it had exceeded its guidance for the 12-months after a record fourth quarter, with net sales of US$77.9 million.

Meso Therapy

THE DETAILS Indeed, FY21 net sales rose 118.3 percent versus 2020 figures, and an impressive 56.2 percent on 2019 while adjusted EBITDA and adjusted EBITDA margin increased to US$32.7 million from US$7.7 million in 2020 and to 12.6 percent from 6.5 percent, respectively.

THE WHY? Q4 sales were driven by continued strength in the US and EMEA as well as significant growth in APAC despite the negative impact from COVID 19. Brent Saunders, BeautyHealth’s Executive Chairman, stated, “We are extremely pleased with our accomplishments this quarter and for the full year 2021, exceeding our guidance. Importantly, we navigated through macro challenges and COVID, delivering strong results by executing against our key strategic initiatives. Our performance is proof of the compelling opportunity we have to capture the convergence of medical aesthetics and skin care.”

Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.

  Aesthetic injectable companies. Dove tackles hair discrimination with ‘as early as five’ campaign

Key aspects of aesthetic injectable companies include:

  • Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.

  • Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.

  • Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.

  • Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.

  • Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.